Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
4
×
gene editing
national top stories
biotech
crispr
deals
editas medicine
feng zhang
san francisco top stories
startups
vc
abbvie
agios therapeutics
allergan
alnylam pharmaceuticals
alzheimer's disease
amy schulman
andreas klein
anna greka
barry greene
base editing
branden moriarty
broad institute
car-t
caron jacobson
cas13
cigall kadoch
clinical trials
craig mello
crispr therapeutics
crispr-cas9
cynthia collins
dan ollendorf
david liu
david walt
What
gene
4
×
editing
medicines
crispr
editas
abbvie
alliance
aren’t
beam
bio
biotech
car
cas
create
cutting
diagnostic
diseases
edge
editor
exits
experimental
experiments
fix
founders
genetic
gotten
harvard
heats
high
hot
human
interference
jump
launch
launches
market
mass
medicine
pact
partnership
Language
unset
Current search:
boston
×
gene
×
" san francisco blog main "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@xconomy.com
6 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M